From The Advisory Board

Treatment Deintensification for HPV-Associated Oropharynx Cancer

Treatment Deintensification for HPV-Associated Oropharynx Cancer

The Eastern Cooperative Oncology Group (ECOG) conducted a trial to investigate whether treatment deintensification was feasible in patients with HPV-associated cancer.

Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Targeted Immunotherapy for Prostate Cancer with PROSTVAC: Interview with Neal Shore, MD, FACS

Neal D. Shore, MD, FACS, sits down with CTA to discuss PROSTVAC as a targeted immunotherapy for prostate cancer.

What to Consider When It Comes to Surgery in Elderly Patients With Cancer

What to Consider When It Comes to Surgery in Elderly Patients With Cancer

Dr. Jeffrey Farma provides his insight on treating the elderly patient population in the surgical oncology setting.

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

Improving Survival in Advanced NSCLC: Multiple Lines of Chemotherapy Make a Difference

Oncologists who care for non-small cell lung cancer (NSCLC) patients need to develop management strategies.

The Resurgence of Interest in Immune Therapy for Metastatic Renal Carcinoma

The Resurgence of Interest in Immune Therapy for Metastatic Renal Carcinoma

Immune therapies hold substantial promise to improve therapeutic options for patients with metastatic renal cancer.

Lost in Translation: Communicating with Newly Diagnosed Cancer Patients

Lost in Translation: Communicating with Newly Diagnosed Cancer Patients

Dr. Dizon and patient advocate Katherine O'Brien discuss the difficulty of communicating cancer and give advice on common miscommunications.

Liberia's Only Internist Dies of Ebola: Remembering Dr. Abraham Borbor

Liberia's Only Internist Dies of Ebola: Remembering Dr. Abraham Borbor

Dr. Burtness, a member of the Cancer Therapy Advisory Board, reflects on the loss of Dr. Abraham Borbor, the only certified internist in Liberia who recently died of Ebola.

The Promise of PD-1/PD-L1 Antagonists in Treating Metastatic Melanoma

The Promise of PD-1/PD-L1 Antagonists in Treating Metastatic Melanoma

Mario Sznol, MD, comments on the results of his phase 1 study reporting on data from patients with metastatic melanoma treated with nivolumab.

New Weapon Against Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

New Weapon Against Advanced Gastric/Gastroesophageal Junction Adenocarcinoma

FDA approval of ramucirumab offers a new therapy option for patients with gastric cancer, which is notoriously aggressive and difficult disease to treat.

Expert Perspectives on Breast Cancer Awareness Month

Expert Perspectives on Breast Cancer Awareness Month

Editorial Board Member Don Dizon, MD, answers some questions about issues in breast cancer treatment today.

Sign Up for Free e-newsletters

Regimen and Drug Listings

GET FULL LISTINGS OF TREATMENT Regimens and Drug INFORMATION

Bone Cancer Regimens Drugs
Brain Cancer Regimens Drugs
Breast Cancer Regimens Drugs
Endocrine Cancer Regimens Drugs
Gastrointestinal Cancer Regimens Drugs
Genitourinary Cancer Regimens Drugs
Gynecologic Cancer Regimens Drugs
Head and Neck Cancer Regimens Drugs
Hematologic Cancer Regimens Drugs
Lung Cancer Regimens Drugs
Other Cancers Regimens
Rare Cancers Regimens
Skin Cancer Regimens Drugs